Omalizumab in Severe and Refractory Solar Urticaria
Clinical trial NCT02262130 · COMPLETED
Trial details
- NCT number
- NCT02262130
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-30
- Primary completion
- 2015-09-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.